Mechanisms of the Relaxation Response in Elderly Hypertensives

老年高血压患者松弛反应的机制

基本信息

  • 批准号:
    7392943
  • 负责人:
  • 金额:
    $ 16.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-15 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Systolic Hypertension is a disorder which is characterized by significant elevations in systolic blood pressure in association with normal diastolic blood pressure. Typically, this develops in individuals >50 years of age and is associated with an increased risk of stroke and myocardial infarction. While there are many effective therapies for essential/diastolic hypertension, the treatment of systolic hypertension is complicated by side effects from traditional therapies. This limits therapeutic options and has resulted in a number of at-risk individuals being left untreated. We have recently completed a preliminary study showing that 8-weeks of relaxation response (RR) training significantly reduced systolic blood pressure in individuals with SH. Systolic blood pressure was significantly decreased by 9.4 mmHg and pulse pressure by 7.9 mmHg. This finding would suggest that the RR may be an effective intervention with few to no adverse consequences in this patient population. In other experiments, we found that the RR increased exhaled nitric oxide in young adult volunteers and plasma nitric oxide in female volunteers. Since nitric oxide levels are low in some patients with essential hypertension, abnormalities in nitric oxide availability could be contributing to SH and might be altered by the RR. However, the actual mechanism by which the RR affects SH remains undetermined. Since the RR is known to alter sympathetic responses, this may be one mechanism which explains the effect of the RR on SH. Other mechanisms contributing to this effect could include alteration of vascular function via changes in nitric oxide production or hormonal alterations in sympathetic arousal (i.e., stress response). We hypothesize that the RR reduces systolic blood pressure and pulse pressure without significant side effects and that this occurs by increasing nitric oxide production and/or by reducing stress hormone levels (epinephrine and cortisol). To examine this hypothesis, we propose conducting a randomized, controlled trial (n=90) in which older adults with SH will receive either 8-weeks of RR intervention or Health Education (HE). The primary outcome is change in systolic blood pressure and pulse pressure. Secondary outcomes are changes in nitric oxide, stress hormones and psychological well-being. Additional analyses will be conducted to assess for other confounding effects on BP and PP. Aim 1: Assess if an 8-week RR intervention will decrease systolic blood pressure and pulse pressure compared with HE (control) without significant side effects. Aim 2: Evaluate whether 8-weeks of RR training increases levels of nitric oxide compared with HE. Aim 3: Assess whether 8-weeks of RR training decreases stress hormones (epinephrine and cortisol) and improves psychological well-being (global severity index and anxiety) compared with HE. While elevated systolic blood pressure and pulse pressure are important risk factors for cardiovascular events, concerns about side effects leave many physicians reluctant to treat this condition. Given the challenges of controlling systolic blood pressure pharmacologically and the prevalence of side effects produced by many antihypertensive agents, identification of non-pharmacologic approaches to decrease systolic blood pressure in older Systolic Hypertension (defined as SBP >140 mm Hg with normal diastolic blood pressure (DBP <90 mm Hg) patients could contribute significantly to the treatment of this condition. These positive effects could have significant economic implications by providing a low-cost adjunctive therapy to current pharmacologic approaches and potentially reduce the incidence of cardiovascular events.
描述(由申请人提供):收缩性高血压是一种以收缩压显着升高而舒张压正常为特征的疾病。通常,这种情况发生在 50 岁以上的个体中,并且与中风和心肌梗塞的风险增加相关。虽然有许多治疗原发性/舒张期高血压的有效疗法,但传统疗法的副作用使收缩期高血压的治疗变得复杂。这限制了治疗选择,并导致许多高危人群得不到治疗。我们最近完成的一项初步研究表明,为期 8 周的放松反应 (RR) 训练可显着降低 SH 患者的收缩压。收缩压显着降低 9.4 mmHg,脉压显着降低 7.9 mmHg。这一发现表明,RR 可能是一种有效的干预措施,对该患者群体几乎没有不良后果。在其他实验中,我们发现 RR 增加了年轻成年志愿者的呼出一氧化氮和女性志愿者的血浆一氧化氮。由于某些原发性高血压患者的一氧化氮水平较低,一氧化氮可用性异常可能会导致 SH,并且可能会被 RR 改变。然而,RR 影响 SH 的实际机制仍未确定。由于已知 RR 会改变交感神经反应,这可能是解释 RR 对 SH 影响的一种机制。促成这种效应的其他机制可能包括通过一氧化氮产生的变化或交感神经兴奋(即应激反应)的激素变化来改变血管功能。我们假设 RR 可以降低收缩压和脉压,而没有明显的副作用,并且这是通过增加一氧化氮的产生和/或降低应激激素水平(肾上腺素和皮质醇)来实现的。为了检验这一假设,我们建议进行一项随机对照试验 (n=90),其中患有 SH 的老年人将接受为期 8 周的 RR 干预或健康教育 (HE)。主要结果是收缩压和脉压的变化。次要结果是一氧化氮、应激激素和心理健康的变化。将进行额外的分析以评估对 BP 和 PP 的其他混杂影响。目标 1:评估 8 周 RR 干预是否会比 HE(对照)降低收缩压和脉压,且没有明显副作用。目标 2:评估与 HE 相比,8 周的 RR 训练是否会增加一氧化氮水平。目标 3:评估与 HE 相比,8 周的 RR 训练是否可以降低压力激素(肾上腺素和皮质醇)并改善心理健康(整体严重指数和焦虑)。虽然收缩压和脉压升高是心血管事件的重要危险因素,但对副作用的担忧使许多医生不愿意治疗这种情况。鉴于药物控制收缩压的挑战以及许多抗高血压药物产生的副作用普遍存在,确定降低老年收缩期高血压(定义为收缩压 >140 mm Hg,舒张压正常)的非药物方法DBP <90 mm Hg)患者可以为这种疾病的治疗做出重大贡献,通过为当前的情况提供低成本的辅助治疗,这些积极效果可能会产生重大的经济影响。药物方法并可能降低心血管事件的发生率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeffery A Dusek其他文献

Mapping Evidence-Based Non-Opioid and Non-Pharmacological Pain Management Modalities Across Minnesota: The Non-Opioid Pain Alleviation Information Network Project.
绘制明尼苏达州循证非阿片类药物和非药理学疼痛管理方式:非阿片类药物疼痛缓解信息网络项目。
Impact of SARS-COV-2 (COVID) Infections on Mental Health Diagnoses in Youth With Chronic Illness
SARS-COV-2 (COVID) 感染对慢性病青少年心理健康诊断的影响
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    M. McVoy;Rina Hung;Irina Bransteter;Jaime A. Perez;Tracy L. Segall;Jessica Surdam;David W. Miller;Jeffery A Dusek;Martha Sajatovic
  • 通讯作者:
    Martha Sajatovic

Jeffery A Dusek的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeffery A Dusek', 18)}}的其他基金

MULTIsite feasibility of MUSIc therapy to address Quality Of Life in Sickle cell disease (MULTI-MUSIQOLS)
MUSIC 疗法解决镰状细胞病生活质量问题的多部位可行性 (MULTI-MUSIQOLS)
  • 批准号:
    10728452
  • 财政年份:
    2023
  • 资助金额:
    $ 16.83万
  • 项目类别:
2022 International Congress on Integrative Medicine and Health
2022 年国际中西医结合医学与健康大会
  • 批准号:
    10468376
  • 财政年份:
    2022
  • 资助金额:
    $ 16.83万
  • 项目类别:
Acupuncture in the Emergency Department for Pain Management: A BraveNet Multi-Center Feasibility Study
急诊科针灸治疗疼痛:BraveNet 多中心可行性研究
  • 批准号:
    10044074
  • 财政年份:
    2020
  • 资助金额:
    $ 16.83万
  • 项目类别:
Acupuncture in the Emergency Department for Pain Management: A BraveNet Multi-Center Feasibility Study
急诊科针灸治疗疼痛:BraveNet 多中心可行性研究
  • 批准号:
    10267175
  • 财政年份:
    2020
  • 资助金额:
    $ 16.83万
  • 项目类别:
Effect of Complementary and Alternative Medicine on Pain Among Inpatients: Admini
补充和替代医学对住院患者疼痛的影响:管理
  • 批准号:
    8490918
  • 财政年份:
    2011
  • 资助金额:
    $ 16.83万
  • 项目类别:
Effect of Complementary and Alternative Medicine on Pain Among Inpatients
补充和替代医学对住院患者疼痛的影响
  • 批准号:
    8269882
  • 财政年份:
    2011
  • 资助金额:
    $ 16.83万
  • 项目类别:
Effect of Complementary and Alternative Medicine on Pain Among Inpatients
补充和替代医学对住院患者疼痛的影响
  • 批准号:
    8075342
  • 财政年份:
    2011
  • 资助金额:
    $ 16.83万
  • 项目类别:
Effect of Complementary and Alternative Medicine on Pain Among Inpatients
补充和替代医学对住院患者疼痛的影响
  • 批准号:
    8496497
  • 财政年份:
    2011
  • 资助金额:
    $ 16.83万
  • 项目类别:
Effect of Complementary and Alternative Medicine on Pain Among Inpatients
补充和替代医学对住院患者疼痛的影响
  • 批准号:
    8668904
  • 财政年份:
    2011
  • 资助金额:
    $ 16.83万
  • 项目类别:
Mechanisms of the Relaxation Response in Elderly Hypertensives
老年高血压患者松弛反应的机制
  • 批准号:
    7686903
  • 财政年份:
    2008
  • 资助金额:
    $ 16.83万
  • 项目类别:

相似国自然基金

单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
  • 批准号:
    82373465
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
  • 批准号:
    82300208
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
  • 批准号:
    82372499
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
  • 批准号:
    10456380
  • 财政年份:
    2023
  • 资助金额:
    $ 16.83万
  • 项目类别:
Traumatic Brain Injury Anti-Seizure Prophylaxis in the Medicare Program
医疗保险计划中的创伤性脑损伤抗癫痫预防
  • 批准号:
    10715238
  • 财政年份:
    2023
  • 资助金额:
    $ 16.83万
  • 项目类别:
The Role of Outpatient Diuretic Therapy in Bronchopulmonary Dysplasia
门诊利尿疗法在支气管肺发育不良中的作用
  • 批准号:
    10663469
  • 财政年份:
    2023
  • 资助金额:
    $ 16.83万
  • 项目类别:
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
一体化、个体化、智能处方(I3P)临床试验网络
  • 批准号:
    10822651
  • 财政年份:
    2023
  • 资助金额:
    $ 16.83万
  • 项目类别:
Selective actin remodeling of sensory neurons for acute pain management
感觉神经元的选择性肌动蛋白重塑用于急性疼痛管理
  • 批准号:
    10603436
  • 财政年份:
    2023
  • 资助金额:
    $ 16.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了